This review mainly highlights the use of polymer–drug conjugates as an advanced drug delivery system to improve the treatment of AD and other neurodegenerative diseases.
No takes yet. Share an insight, caveat, or question.
Mahadik et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: